dr. adriane fugh-berman. -- has been dr. adriane fugh-berman. o teachers at georgetown university. -- she teaches at georgetown university. we thank you very much. dr. fugh-berman: thank you. announcer: four free transcripts or to give comments visit us at q&a.org. programs are also available as podcasts. as c-span marks 10 years of compelling conversations on q and a, here are some other programs you might like. ralph nader discussing his new book. dr. anthony faucchi talking about his work. you can watch these interviews and her time -- interviews anytime or search our entire library at c-span.org. on the next "washington journal" , william kristol, weekly standard founder and editor will talk about the events surrounding this week's iranian nuclear negotiations and other issues. health care reporter kimberly leonard has the latest on health care law enrollments and cost projections. and the aggregator -- the agriculture undersecretary talks about changes to the national school lunch programs. washington journal, live at 7:00 a.m. to time on c-

dr. adriane fugh-berman. she keeps nra on the lobbying practices of pharmaceutical industry.an: if you could change one thing about the pharmaceutical industry and its relationship to doctors or patients, what would you do? dr. fugh-berman: i would get them out of educating consumers, they are unable to be objective and there are a lot of marketing messages in the education that they do with doctors through continuing medical education which is required for most physicians or through disease awareness initiatives aimed at either consumers or health care providers. there is a lot of distortion that happens because of the pharmaceutical industry and we need to make sure that the information that health care providers and consumers have is accurate. we will never get that from pharmaceutical companies. brian: why not? dr. fugh-berman: they are legally obligated to represent interests of their shareholders

dr. adriane fugh-berman. she teaches at georgetown university. we thank you very much. dr.ugh-berman: thank you. ♪ announcer: for free transcripts or to give comments, visit us at q&a.org. programs are also available as c-span podcasts. >> c-span marks 10 years of compelling conversations on q&a. here are some others you might like. that ralph nader discussing his new book. and melodies one, the executive or of citizens for responsible ethics in washington. you can watch these any time or see our library at c-span.org. >> next, live at 7 a.m., your calls and comments on washington journal. it live it new, the house of representatives gavels in. >> tonight on the communicators, fcc communicator on the recent net neutrality ruling, broadband, and lifeline. >> what i am buzzing that we do is overhaul the lifeline program and make it concurrent ent in sync with the information age. challenge providers to give more to consumers. cases have been explosive for the rest of us, it should be for a lot of consumers. get those providers out of the certification business. that is the nu

dr. adriane fugh-berman. she treaches at georgetown university. and we thank you very much for your time. dr. fugh-berman: thank you. announcer: for free transcripts or to give comments visit us at q&a.org. q&a programs are also available on c-span's podcast. announcer: c-span marks 10 years on compelling conversations on q1 day here are some other programs if you enjoyed this week's interview aired.

dr. adrian few berman. then david cameron takes questions from the house of commons. ted cruz was the featured speaker today at this♪ announcer: as we our -- as we our guest is dr. adriane fugherman. she jeeps and all on the lobbying practices of the pharmaceutical interest -- keeps nra on the lobbying practices of pharmaceutical industry/ brian: if you could change one thing about the pharmaceutical industry and its relationship to doctors or patrons, what would you do -- patients, what would

dr. adrian -- director of watchdog project farmed out on how pharmaceutical companies influence congress and doctors on what medications to prescribe. dr. fugh-bermanwhile it is illegal for a company to market a drug before it has been approved by the fda, it is not illegal to market a disease, so drug companies have sometimes invented diseases or exaggerated the importance of certain conditions, or exaggerated the importance of a particular mechanism of a drug, for example, and then blanketed medical journals and medical meetings and other venues with these messages that are meant to prepare the minds of clinicians to accept a particular drug, and also to prepare the minds of consumers to accept a particular condition. >> sunday night at 8:00 eastern and pacific on c-span's "q&a." >> live today on c-span, "washington journal" is next. in a 1:00 p.m. eastern, kentucky senator rand paul visits luis state university in maryland to discuss overhauling the criminal justice system. at 7:45 p.m. from dover, new hampshire, a meet and greet for former florida governor jeb bush. coming up in 45 minutes on "washington journal," trita parsi of the national ir